Feasibility of Transepicardial Atrial Injection
NCT05634213
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Logistical issues
Conditions
Cardiac Surgery
Interventions
DRUG:
normal saline
Sponsor
Ottawa Heart Institute Research Corporation